My Size, Inc. Files Definitive Proxy Statement

TL;DR

MYSI proxy filing is in, standard shareholder meeting stuff.

AI Summary

My Size, Inc. filed a Definitive Proxy Statement (DEF 14A) on November 4, 2024. The filing concerns the company's proxy materials, which are typically used for shareholder meetings to vote on corporate matters. The company, formerly known as Topspin Medical Inc., is incorporated in Delaware and has its principal business address in Airport City, Israel.

Why It Matters

This filing is a standard regulatory requirement for public companies, indicating that My Size, Inc. is preparing for or has held a shareholder meeting where important corporate decisions are made.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial information or strategic changes that would inherently increase risk.

Key Players & Entities

• My Size, Inc. (company) — Registrant
• Topspin Medical Inc. (company) — Former company name
• November 4, 2024 (date) — Filing date

FAQ

Filing Documents

• def14a.htm (DEF 14A) — 278KB
• proxy_001.jpg (GRAPHIC) — 243KB
• proxy_002.jpg (GRAPHIC) — 403KB
• 0001493152-24-043547.txt ( ) — 1169KB

From the Filing

DEF 14A 1 def14a.htm UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 MY SIZE, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a–6(i)(1) and 0–11 MY SIZE, INC. NOTICE OF ANNUAL MEETING AND PROXY Meeting to be held on December 30, 2024, at 10:00 a.m. (local time) At the Offices of Barnea Jaffa Lande & Co Law Offices, 58 HaRakevet St., Tel Aviv 6777016, Israel MY SIZE, INC. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 30, 2024 An annual meeting of stockholders (the “Annual Meeting”) of My Size, Inc. (“My Size”, the “Company”, “we”, “us”, or “our”) will be held on December 30, 2024, at the offices of Barnea Jaffa Lande & Co Law Offices, 58 HaRakevet St., Tel Aviv 6777016, Israel at 10:00 a.m. (local time), to consider the following proposals: 1. To elect a Class III director to serve on our board of directors to serve on our board of directors for a term of three years or until his successor is elected and qualified, for which Ronen Luzon is the nominee; 2. To ratify the appointment of Somekh Chaikin as our independent public accountant for the fiscal year ending December 31, 2024; and 3. To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof. BECAUSE OF THE SIGNIFICANCE OF THESE PROPOSALS TO THE COMPANY AND ITS STOCKHOLDERS, IT IS VITAL THAT EVERY STOCKHOLDER VOTES AT THE ANNUAL MEETING IN PERSON OR BY PROXY. Under Securities and Exchange Commission rules that allow companies to furnish proxy materials to stockholders over the Internet, we have elected to deliver our proxy materials to our stockholders over the Internet. This delivery process allows us to provide stockholders with the information they need, while at the same time conserving natural resources and lowering the cost of delivery. On or about November 4, 2024, we intend to begin sending to our stockholders a Notice of Internet Availability of Proxy Materials (the “Notice”) containing instructions on how to access our proxy statement for our annual meeting of stockholders and our 2023 Annual Report on Form 10-K. The Notice also provides instructions on how to vote online and how to receive a paper copy of the proxy materials by mail. These proposals are fully set forth in the accompanying Proxy Statement, which you are urged to read thoroughly. For the reasons set forth in the Proxy Statement, your board of directors recommends a vote “FOR” Proposals 1 and 2. Only stockholders of record at the close of business on November 4, 2024 (the “Record Date”) will be entitled to attend and vote at the meeting. A list of all stockholders entitled to vote at the Annual Meeting will be available at the principal office of the Company during usual business hours, for examination by any stockholder for any purpose germane to the Annual Meeting for 10 days prior to the date thereof. Stockholders are cordially invited to attend the Annual Meeting. However, whether or not you plan to attend the meeting in person, your shares should be represented and voted. After reading the enclosed Proxy Statement, please sign, date, and return promptly the enclosed Proxy in the accompanying postpaid envelope we have provided for your convenience to ensure that your shares will be represented. If you do attend the meeting and wish to vote your shares personally, you may revoke your Proxy. By Order of the Board of Directors /s/ Ronen Luzon Ronen Luzon Member of the Board of Directors November 4, 2024 WHETHER OR NOT YOU PLAN ON ATTENDING THE MEETING IN PERSON, PLEASE VOTE AS PROMPTLY AS POSSIBLE TO ENSURE THAT YOUR VOTE IS COUNTED. IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL STOCKHOLDER MEETING TO BE HELD ON DECEMBER 19, 2024: Our Notice of Annual Meeting of Stockholders, Proxy Statement, Proxy Card and 2023 Annual Report to Stockholders are available at: www.proxyvote.com TABLE OF CONTENTS PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS 1 QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING OF STOCKHOLDERS 1 PROPOSAL ONE –ELECTION OF CLASS 3 DIRECTORS 6 PROPOSAL TWO – RATIFICATION OF THE RE-APPOIN

View Full Filing

View this DEF 14A filing on SEC EDGAR